Cervical cancer
Conditions
Interventions
Usual Care Group:Participants in the usual care group will receive standard immunization services, which include a letter to parents distributed by the Center for Dise
Intervention Group:The intervention group will implement an integrated implementation strategy involving multiple stakeholders on top of routine service procedures, incl
Sponsors
Nanjing Medical University
Eligibility
Sex/Gender
All
Age
11 Years to No maximum
Inclusion criteria
Inclusion criteria: The study participants are female junior high school students who have not received the HPV vaccine and their guardians. Inclusion criteria for adolescents are: 1) Currently enrolled female students in junior high school; 2) Have not received the HPV vaccine; 3) Are in good health with no contraindications to vaccination; 4) Are willing to participate in this project and sign an informed consent form. Guardian inclusion criteria: 1) Legal guardian of the aforementioned adolescent; 2) Understanding of the study objectives and procedures, with willingness to support the adolescent's participation; 3) Willingness to participate in this project and sign an informed consent form.
Exclusion criteria
Exclusion criteria: Adolescents will be excluded if they meet any of the following criteria: 1.Have previously received the HPV vaccine; 2.Have a history of severe allergy to vaccination, or are allergic to any component of the HPV vaccine; 3.Other conditions deemed by the investigator to be unsuitable for participation in this study. Guardians will be excluded if they meet any of the following criteria: 1.Unable to understand the purpose and procedures of the study (e.g., due to cognitive impairment, language barriers, etc.); 2.Refuse to sign the informed consent form for themselves or for the adolescent under their care; 3.Other conditions deemed by the investigator that may prevent completion of the study procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| First-dose HPV vaccine uptake; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaccine delay;Acceptability;Vaccine confidence;Appropriateness;Feasibility;Fidelity; | — |
Countries
China
Contacts
Public ContactDan Wu
Nanjing Medical University
Outcome results
None listed